Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-27

Clinical Trial Update: Greek NIS Spiolto ELLACTO

View source ↗

Summary

Clinical trial update for the Spiolto EllACTO study in COPD has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spiolto EllACTO (tiotropium/olodaterol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2020-04-27